Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38327
CAS Number:
251565-85-2
Tesaglitazar
Purity:
≥ 95 % (HPLC)
Synonym(s):
Ácido ( S )-2-etoxi-3-[4-[2-(4-metanosulfoniloxifenil)etoxi]fenil]propanoico, Ácido ( S )-2-etoxi-3-[4-[4-[(metilsulfonil)oxi]fenetoxi]fenil]propanoico
Documents
$363.84 /25 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
Ácido ( S )-2-etoxi-3-[4-[2-(4-metanosulfoniloxifenil)etoxi]fenil]propanoico, Ácido ( S )-2-etoxi-3-[4-[4-[(metilsulfonil)oxi]fenetoxi]fenil]propanoico
CAS Number
251565-85-2
Purity
≥ 95 % (HPLC)
Molecular Formula
C20H24O7S
Molecular Weight
408.47
MDL Number
MFCD07784004
PubChem ID
11338777
Appearance
Polvo de color blanco a amarillo claro hasta cristal.
Optical Rotation
-17 a -21° (C=1, AcOEt)
Conditions
Conservar entre 2 y 8 °C.
General Information
Synonyms
Ácido ( S )-2-etoxi-3-[4-[2-(4-metanosulfoniloxifenil)etoxi]fenil]propanoico, Ácido ( S )-2-etoxi-3-[4-[4-[(metilsulfonil)oxi]fenetoxi]fenil]propanoico
CAS Number
251565-85-2
Purity
≥ 95 % (HPLC)
Molecular Formula
C20H24O7S
Molecular Weight
408.47
MDL Number
MFCD07784004
PubChem ID
11338777
Appearance
Polvo de color blanco a amarillo claro hasta cristal.
Optical Rotation
-17 a -21° (C=1, AcOEt)
Conditions
Conservar entre 2 y 8 °C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Tesaglitazar is widely utilized in research focused on

  • Diabetes Management: This compound has been studied for its potential in treating type 2 diabetes by improving insulin sensitivity and glucose metabolism, making it a valuable asset in diabetes research.
  • Cardiovascular Health: Tesaglitazar has shown promise in reducing cardiovascular risks associated with metabolic syndrome, which is crucial for developing therapies aimed at heart health.
  • Anti-inflammatory Applications: Its anti-inflammatory properties are being explored for conditions like arthritis, providing a potential alternative to traditional anti-inflammatory medications.
  • Drug Development: Researchers are investigating its unique mechanism of action for developing new drugs that target multiple pathways in metabolic diseases, offering a broader therapeutic approach.
  • Pharmaceutical Formulations: The compound's chemical stability and solubility make it suitable for various pharmaceutical formulations, enhancing the effectiveness of medications in clinical settings.

Citas